Generics 26

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrrolate manufacturers

26 products found

Filters

26 products found

glycopyrrolate

Vials, injection 0.2 mg / 1 ml, 0.4 mg / 1 ml, 1 mg / 5 ml, 4 mg / 20 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18871
This American pharmaceutical company specializes in manufacturing and supplying affordable generic medications across various therapeutic areas. With over a decade of experience, they offer a wide range of bioequivalent alternatives, including injectables, ophthalmics, oral solutions, and oral solids. Their commitment to innovation and quality is reflected in their state-of-the-art manufacturing facilities and robust intellectual property pipeline. The company prioritizes patient safety and efficacy, adhering to strict GMP certifications and holding product patents. They serve patients, caregivers, and healthcare professionals across the EU, North America, and other regions.

Manufacturer usually replies in 4 days

glycopyrrolate

Vials, injection 0.2 mg / ml, 0.4 mg / 2 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18856
This integrated pharmaceutical company specializes in developing and manufacturing sterile injectable products, including liquid vials, IV bags, lyophilized vials, and pre-filled syringes. They offer both proprietary and generic options, targeting key therapy areas such as [you'll need to fill in specific therapy areas mentioned in the text]. Their facilities, located in North America, are FDA inspected and boast significant excess capacity for CDMO opportunities. The company emphasizes quality control with GMP certifications and has a strong track record of successful FDA inspections. They also prioritize sustainability by investing in local communities and training programs.

Manufacturer usually replies in 3 days

glycopyrrolate

Inhalation powder tbd

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #13159
This company is a driving force in developing innovative treatments and technologies for a range of medical needs. Focusing on areas like psychiatry & neurology, oncology, urology, women's health, rare disease, and cell & gene therapy, they have a diverse pipeline of preclinical and clinical programs. Their technology-driven approach aims to bring patient-first solutions to market faster. While specific details about their production lines (prescription medications, over-the-counter drugs, medical devices, supplements) and GMP certifications are not provided, their commitment to research and development in key therapy areas suggests a broad scope of products. The company operates in regions like the EU and North America, emphasizing global impact.

Manufacturer usually replies in 3 days

Want to see all 26 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible